Virtus Alternative Investment Advisers’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-124	Closed	-$16K	–	276
2020 Q4	$16K	Sell	124 -121	-49%	-$10.7K	0.24%	43
2020 Q3	$12K	Sell	245 -10	-4%	-$450	0.22%	82
2020 Q2	$12K	Buy	+255	New	+$11.9K	0.19%	250

Virtus Alternative Investment Advisers's EIDX Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 124 shares — an estimated $16K sold.

Virtus Alternative Investment Advisers first reported a position in EIDX in Q2 2020 and held it in 3 quarters. The position peaked at $16K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Virtus Alternative Investment Advisers reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Virtus Alternative Investment Advisers sold 124 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $16K.
Virtus Alternative Investment Advisers first reported a position in Eidos Therapeutics, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Virtus Alternative Investment Advisers's Eidos Therapeutics, Inc. Common Stock position peaked at $16K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.